Shopping cart

Magazines cover a wide array subjects, including but not limited to fashion, lifestyle, health, politics, business, Entertainment, sports, science,

  • Home
  • Euronews
  • Pfizer stops work on potential obesity pill over patient liver injury
Euronews

Pfizer stops work on potential obesity pill over patient liver injury

By - Admin April 15, 2025 Comments (0) 1 Mins Read
Email :2


Pfizer had intended to move the drug into late-stage testing, but called it quits after a patient in a clinical trial experienced a potentially drug-related liver injury.

Source

img

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Canada’s PM Carney plans for stronger

BY-Admin April 19, 2025

Towards more resilient health systems in

BY-Admin April 19, 2025

EU Countries Seek to Limit Hungary’s

BY-Admin April 19, 2025
Euronews

Polish presidential elections 2025: who is

BY-Admin April 19, 2025

Haiti’s independence debt to France focus

BY-Admin April 19, 2025

Anti-Trump administration protesters turn out for

BY-Admin April 19, 2025